diphenylamine has been researched along with bromodeoxyuridine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, Q; Chapman, MS; Hedley, DW; Miner, JN | 1 |
| Griffith, LG; Hang, TC; Lauffenburger, DA; Stolz, DB | 1 |
2 other study(ies) available for diphenylamine and bromodeoxyuridine
| Article | Year |
|---|---|
Antitumour activity of a potent MEK inhibitor RDEA119/BAY 869766 combined with rapamycin in human orthotopic primary pancreatic cancer xenografts.
Topics: Animals; Antineoplastic Agents; Bromodeoxyuridine; Cell Cycle; Cell Line, Tumor; Diphenylamine; Enzyme Inhibitors; Humans; Male; MAP Kinase Kinase Kinases; Mice; Neoplasm Transplantation; Pancreatic Neoplasms; Signal Transduction; Sirolimus; Sulfonamides | 2010 |
Lipids promote survival, proliferation, and maintenance of differentiation of rat liver sinusoidal endothelial cells in vitro.
Topics: Animals; Benzamides; Bromodeoxyuridine; Cell Death; Cell Differentiation; Cell Proliferation; Cell Survival; Chromones; Culture Media, Serum-Free; Diphenylamine; Endocytosis; Endothelial Cells; Fatty Acids, Nonesterified; Liver; Male; MAP Kinase Kinase 1; MAP Kinase Kinase 2; MAP Kinase Signaling System; Microscopy, Electron, Scanning; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Morpholines; Oleic Acid; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Platelet Endothelial Cell Adhesion Molecule-1; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-akt; Rats; Rats, Inbred F344; Receptors, IgG | 2012 |